M&A Deal Summary

Ketamine One Acquires KGK Science

On May 27, 2021, Ketamine One acquired life science company KGK Science from Auxly for 17M USD

Acquisition Highlights
  • This is Ketamine One’s 1st transaction in the Life Science sector.
  • This is Ketamine One’s largest (disclosed) transaction.
  • This is Ketamine One’s 2nd transaction in Canada.
  • This is Ketamine One’s 1st transaction in Ontario.

M&A Deal Summary
Date 2021-05-27
Target KGK Science
Sector Life Science
Buyer(s) Ketamine One
Sellers(s) Auxly
Deal Type Divestiture
Deal Value 17M USD

Target

KGK Science

London, Ontario, Canada
Founded in 1997, KGK Science is a contract research organization based in London, Ontario that primarily provides high-quality clinical research trials with a focus on the nutraceutical, cannabis, and emerging psychedelic industries. For over 23 years, the business has successfully helped hundreds of companies with custom-designed clinical trials and claim substantiation strategies to move products into global markets. KGK’s other existing service lines include expert regulatory support and compliance solutions, participant recruitment, research support services, and consulting services. On an approximate basis, the business to date has produced 150 publications, executed over 400 clinical trials across more than 40 indications, amassed 25,000 participants in its database, and collected 10 million data points.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Ketamine One

Vancouver, British Columbia, Canada
Category Company
Founded 2017
Sector Business Services
DESCRIPTION

Ketamine One is a single-purpose company focused in mental health. In 2021, the Company has acquired a network of 14 national medical cannabis clinics as well as KGK Science Inc., a leading North American contract research organization that provides high-quality clinical research trials with a focus on the nutraceutical, cannabis and emerging psychedelic industries. Ketamine One was founded in 2017 and is headquartered in Vancouver, Canada.

DEAL STATS #
Overall 2 of 2
Sector (Life Science) 1 of 1
Type (Divestiture) 1 of 1
State (Ontario) 1 of 1
Country (Canada) 2 of 2
Year (2021) 2 of 2
Size (of disclosed) 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-04-23 Integrated Rehab and Performance

Victoria, British Columbia, Canada

Integrated Rehab and Performance operates multidisciplinary physical therapy clinic exclusively for patients who are past or present personnel of the Canadian Armed Forces or Royal Canadian Mounted Police, and first responders (e.g., firefighters, law enforcement officers, paramedics, EMTs, etc.). Integrated Rehab and Performance was formed in 2018 and is based in Victoria, British Columbia.

Buy $1M

Seller(S) 1

SELLER

Auxly

Toronto, Ontario, Canada
Category Company
Founded 1987
Sector Business Services
Employees369
Revenue 101M USD (2023)
DESCRIPTION

Auxly is a vertically integrated cannabis company with diverse international operations. Auxly was founded in 1987 and is headquartered in Toronto, Ontario.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Divestiture) 1 of 1
State (Ontario) 1 of 1
Country (Canada) 1 of 1
Year (2021) 1 of 1
Size (of disclosed) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2019-01-24 Curative Cannabis

Ontario, Canada

2368523 Ontario Ltd. is a provider of ultra-premium cannabis product.

Buy -
Mergr

Product

Company

Legal